Literature DB >> 16436753

Piperine, a phytochemical potentiator of ciprofloxacin against Staphylococcus aureus.

Inshad Ali Khan1, Zahid Mehmood Mirza, Ashwani Kumar, Vijeshwar Verma, Ghulam Nabi Qazi.   

Abstract

Piperine, a trans-trans isomer of 1-piperoyl-piperidine, in combination with ciprofloxacin markedly reduced the MICs and mutation prevention concentration of ciprofloxacin for Staphylococcus aureus, including methicillin-resistant S. aureus. The enhanced accumulation and decreased efflux of ethidium bromide in the wild-type and mutant (CIPr-1) strains in the presence of piperine suggest its involvement in the inhibition of bacterial efflux pumps.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16436753      PMCID: PMC1366922          DOI: 10.1128/AAC.50.2.810-812.2006

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea-pig small intestine: evidence that piperine lowers the endogeneous UDP-glucuronic acid content.

Authors:  J Singh; R K Dubey; C K Atal
Journal:  J Pharmacol Exp Ther       Date:  1986-02       Impact factor: 4.030

2.  Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs.

Authors:  C K Atal; U Zutshi; P G Rao
Journal:  J Ethnopharmacol       Date:  1981-09       Impact factor: 4.360

3.  Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones.

Authors:  E Pestova; J J Millichap; G A Noskin; L R Peterson
Journal:  J Antimicrob Chemother       Date:  2000-05       Impact factor: 5.790

4.  Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones.

Authors:  H Yoshida; M Bogaki; S Nakamura; K Ubukata; M Konno
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

5.  Relative potential for selection of fluoroquinolone-resistant Streptococcus pneumoniae strains by levofloxacin: comparison with ciprofloxacin, sparfloxacin and ofloxacin.

Authors:  H B Drugeon; M E Juvin; A Bryskier
Journal:  J Antimicrob Chemother       Date:  1999-06       Impact factor: 5.790

Review 6.  NCCLS perspectives in changing susceptibility breakpoints for antimicrobial drugs.

Authors:  John G Gums
Journal:  Int J Antimicrob Agents       Date:  2003-10       Impact factor: 5.283

7.  Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4.

Authors:  Rajinder K Bhardwaj; Hartmut Glaeser; Laurent Becquemont; Ulrich Klotz; Suresh K Gupta; Martin F Fromm
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

8.  A novel locus conferring fluoroquinolone resistance in Staphylococcus aureus.

Authors:  M Trucksis; J S Wolfson; D C Hooper
Journal:  J Bacteriol       Date:  1991-09       Impact factor: 3.490

9.  A novel inhibitor of multidrug efflux pumps in Staphylococcus aureus.

Authors:  Simon Gibbons; Moyosoluwa Oluwatuyi; Glenn W Kaatz
Journal:  J Antimicrob Chemother       Date:  2003-01       Impact factor: 5.790

10.  Biochemical basis of enhanced drug bioavailability by piperine: evidence that piperine is a potent inhibitor of drug metabolism.

Authors:  C K Atal; R K Dubey; J Singh
Journal:  J Pharmacol Exp Ther       Date:  1985-01       Impact factor: 4.030

View more
  32 in total

Review 1.  Efflux-mediated drug resistance in bacteria: an update.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2009-08-20       Impact factor: 9.546

2.  Piperine treatment suppresses Helicobacter pylori toxin entry in to gastric epithelium and minimizes β-catenin mediated oncogenesis and IL-8 secretion in vitro.

Authors:  Nagendran Tharmalingam; Min Park; Min Ho Lee; Hyun Jun Woo; Hyun Woo Kim; Ji Yeong Yang; Ki-Jong Rhee; Jong-Bae Kim
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

3.  Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal).

Authors:  Emily R Britton; Joshua J Kellogg; Olav M Kvalheim; Nadja B Cech
Journal:  J Nat Prod       Date:  2017-11-01       Impact factor: 4.050

4.  Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.

Authors:  Arunasree M Kalle; Arshad Rizvi
Journal:  Antimicrob Agents Chemother       Date:  2010-10-11       Impact factor: 5.191

5.  Inhibitory and resistance-modifying potential of plant-based alkaloids against methicillin-resistant Staphylococcus aureus (MRSA).

Authors:  Mastura Mohtar; Saiful Azmi Johari; Abdul Rashid Li; Mazurah Mohamed Isa; Shuhaimi Mustafa; Abdul Manaf Ali; Dayang Fredalina Basri
Journal:  Curr Microbiol       Date:  2009-05-28       Impact factor: 2.188

6.  The toxic effects of piperine against Trypanosoma cruzi: ultrastructural alterations and reversible blockage of cytokinesis in epimastigote forms.

Authors:  Leonardo Freire-de-Lima; Tatiana Santana Ribeiro; Gustavo Miranda Rocha; Bruno Alves Brandão; Alexandre Romeiro; Lucia Mendonça-Previato; José Osvaldo Previato; Marco Edilson Freire de Lima; Técia Maria Ulisses de Carvalho; Norton Heise
Journal:  Parasitol Res       Date:  2008-01-29       Impact factor: 2.289

Review 7.  A comprehensive review on pharmacotherapeutics of herbal bioenhancers.

Authors:  Ghanshyam B Dudhatra; Shailesh K Mody; Madhavi M Awale; Hitesh B Patel; Chirag M Modi; Avinash Kumar; Divyesh R Kamani; Bhavesh N Chauhan
Journal:  ScientificWorldJournal       Date:  2012-09-17

8.  Bioenhancers: Revolutionary concept to market.

Authors:  Navin Atal; K L Bedi
Journal:  J Ayurveda Integr Med       Date:  2010-04

9.  Bactericidal antibiotic-phytochemical combinations against methicillin resistant Staphylococcus aureus.

Authors:  Bhone Myint Kyaw; Shuchi Arora; Chu Sing Lim
Journal:  Braz J Microbiol       Date:  2012-06-01       Impact factor: 2.476

10.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.